915107-31-2

Basic information

• Product Name: 6-Chloro-5-methoxy-nicotinic acid methyl ester
• Synonyms: 6-Chloro-5-methoxy-nicotinic acid methyl ester;Methyl 6-chloro-5-Methoxypyridine-3-carboxylate;Methyl 6-chloro-5-Methoxynicotinate;Methyl 6-chloro-5-methoxypyridine-3-carboxylate, 2-Chloro-3-methoxy-5-(methoxycarbonyl)pyridine
• CAS NO: 915107-31-2
• Molecular Formula: C₈H₈ClNO₃
• Molecular Weight: 202
• EINECS: 604-604-1
• Mol File: 915107-31-2.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 6-Chloro-5-methoxy-nicotinic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Chloro-5-methoxy-nicotinic acid methyl ester(915107-31-2)
• EPA Substance Registry System: 6-Chloro-5-methoxy-nicotinic acid methyl ester(915107-31-2)

Safety Data

• Hazardous Substances Data: 915107-31-2(Hazardous Substances Data)

Usage

General Description

6-Chloro-5-methoxy-nicotinic acid methyl ester is a chemical compound that belongs to the family of organic compounds known as pyridines and derivatives. 6-Chloro-5-methoxy-nicotinic acid methyl ester has a molecular formula of C8H8ClNO3 and a molecular weight of 207.61 g/mol. It is commonly used in the pharmaceutical and research industries for its potential therapeutic applications and pharmacological properties. 6-Chloro-5-methoxy-nicotinic acid methyl ester may have anti-inflammatory, anti-cancer, and anti-viral activities, and its derivatives are being studied for their potential as drug candidates. Additionally, it may also have applications in the field of organic synthesis and medicinal chemistry.

Upstream product

• 915107-30-1 methyl 6-chloro-5-hydroxypyridine-3-carboxylate 
• 74-88-4 methyl iodide 
• 30766-22-4 methyl 5-hydroxy-3-pyridinecarboxylate 

Downstream Products

• 915107-39-0 6-chloro-5-methoxynicotinic acid 
• 915107-47-0 (6-chloro-5-methoxypyridin-3-yl)methanol 
• 380912-09-4 5-hydroxy imidacloprid 

Relevant articles and documents

Synthesis method of imidacloprid metabolite 5-hydroxyimidacloprid

The invention discloses a synthesis method of an imidacloprid metabolite 5-hydroxyimidacloprid, and belongs to the field of medicine synthesis. According to the synthesis method, methyl 5-hydroxynicotinate is used as a raw material, synthesis of the imidacloprid metabolite 5-hydroxylimidacloprid is achieved for the first time through six-step reaction, an optimal synthesis route and reaction conditions are screened out through a large number of experiments, the purity of the prepared target product can reach 99% or above, and the target product does not contain raw material medicine imidacloprid can be used for research on pharmacokinetics, raw material medicine impurity identification, environment control and protection and the like, provides a sample for impurity identification of imidacloprid, metabolic mechanism research, influence on the environment after medicine use, how to carry out corresponding protection and the like, and has important application value.

NOVEL HETEROARYL IMIDAZOLES AND HETEROARYL TRIAZOLES AS GAMMA-SECRETASE MODULATORS

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I; (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 066

The invention provides compounds of formula wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.